The best combination for the treatment of Hidradenitis Suppurativa - Dr. Anuj Pall MD, PhD - YouTube
An extraordinary form of the Melkersson-Rosenthal syndrome successfully treated with the tumour necrosis factor-α blocker adalimumab | BMJ Case Reports
Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial - The Lancet
View Image
ESPRIT: 10-year post-marketing surveillance registry of adalimumab for moderate to severe psoriasis: All treatment-emergent mali
Protect at all costs: How the maker of the world's bestselling drug keeps prices sky-high | Fortune
Early administration of adalimumab for paediatric uveitis due to Behçet's disease | Pediatric Rheumatology | Full Text
Adalimumab Effective in Pediatric Plaque Psoriasis | RheumNow
Tocilizumab in patients with anti-TNF refractory juvenile idiopathic arthritis-associated uveitis (APTITUDE): a multicentre, single-arm, phase 2 trial - The Lancet Rheumatology
Refractory dissecting Cellulitis of the Scalp Successfully controlled with Adalimumab. | Semantic Scholar
Treatment of Recalcitrant Generalized Granuloma Annulare With Adalimumab - JDDonline - Journal of Drugs in Dermatology
Overview of Humira® Biosimilars: Current European Landscape and Future Implications - Journal of Pharmaceutical Sciences
Treatment of Hidradenitis Suppurativa in 2021 & Beyond - Next Steps in Dermatology
Excimer Laser Therapy for Hairline Psoriasis: A Useful Addition to the Scalp Psoriasis Treatment Algorithm
Efficacy of Adalimumab for Nail Psoriasis During 24 Months of Continuous Therapy | HTML | Acta Dermato-Venereologica
Chronic verrucous sarcoidosis associated with human papillomavirus infection: Improvement with adalimumab | Semantic Scholar
JCM | Free Full-Text | The Optimal Management of Fistulizing Crohn’s Disease: Evidence beyond Randomized Clinical Trials
AbbVie, Johnson & Johnson Lead US Immunology Drug Market Due to High Cost of Biologic Treatments - iData Research
Guselkumab Effective for Treatment of Moderate-to-Severe Plaque Psoriasis
Excimer Laser Therapy for Hairline Psoriasis: A Useful Addition to the Scalp Psoriasis Treatment Algorithm
PHARMACY POLICY STATEMENT
Phototherapy remains a valuable psoriasis treatment
Potential predictive biomarkers of adalimumab response in patients with hidradenitis suppurativa* - Cao - 2021 - British Journal of Dermatology - Wiley Online Library
Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial - ScienceDirect
Cureus | Erythema Dyschromicum Perstans After Adalimumab Treatment
